Clinical trial
Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of Refractory Autoimmune Diseases
NCT06316791 is registered in ClinicalTrials.gov with Juventas Cell Therapy Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of Refractory Autoimmune Diseases
- Lead sponsor
- Juventas Cell Therapy Ltd.
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- December 14, 2021
- Completion date
- December 13, 2025
- Enrollment
- 24 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.